Subtopic Deep Dive
SOD1 Mutations in Familial ALS
Research Guide
What is SOD1 Mutations in Familial ALS?
SOD1 mutations cause 20% of familial ALS through protein misfolding, mitochondrial vacuolar degeneration, and ER stress, driving motor neuron toxicity.
Over 180 SOD1 mutations link to familial ALS, first identified in 1993 (Rosen et al., 1993, 6967 citations). Mutant SOD1 induces toxic gain-of-function via aggregation independent of enzymatic activity (Bruijn et al., 1998, 1218 citations). Transgenic models show vacuolar mitochondrial damage as a key pathology (Wong et al., 1995, 1429 citations).
Why It Matters
SOD1 mutations established ALS genetic models, enabling therapies like tofersen antisense oligonucleotide targeting mutant SOD1 transcripts. Pioneered gene silencing strategies now applied to C9orf72 and FUS (Renton et al., 2011, 4358 citations). SOD1 mouse models revealed non-cell-autonomous toxicity involving glia (Boillée et al., 2006, 1405 citations), informing multisystem ALS trials. Impacts 2-5% of all ALS cases with familial clustering.
Key Research Challenges
Mutant SOD1 Aggregation Mechanisms
Mutant SOD1 forms toxic aggregates independent of wild-type SOD1, causing motor neuron death (Bruijn et al., 1998). Challenges persist in distinguishing aggregation from loss-of-function. Transgenic models confirm mitochondrial vacuolization precedes symptoms (Wong et al., 1995).
Non-Cell-Autonomous Toxicity
SOD1 mutant toxicity spreads from motor neurons to glia and microglia (Boillée et al., 2006). Microglial activation accelerates disease in chimeric models. Targeting neuronal vs. non-neuronal cells shows differential impacts (Renton et al., 2013).
Therapeutic Silencing Selectivity
Antisense oligonucleotides silence mutant SOD1 but risk wild-type depletion. Delivery across blood-brain barrier limits efficacy. Genetic reviews highlight SOD1 as 20% familial ALS cause needing precise intervention (Renton et al., 2013).
Essential Papers
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
D.R. Rosen, Teepu Siddique, David T. Patterson et al. · 1993 · Nature · 7.0K citations
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Alan E. Renton, Elisa Majounie, Adrian J. Waite et al. · 2011 · Neuron · 4.4K citations
State of play in amyotrophic lateral sclerosis genetics
Alan E. Renton, Adriano Chiò, Bryan J. Traynor · 2013 · Nature Neuroscience · 1.5K citations
Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
Peter T. Nelson, Dennis W. Dickson, John Q. Trojanowski et al. · 2019 · Brain · 1.4K citations
We describe a recently recognized disease entity, limbic-predominant age-related TDP-43 encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a stereotypical TDP-43 proteinop...
An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
Philip C. Wong, Carlos A. Pardo, David Borchelt et al. · 1995 · Neuron · 1.4K citations
ALS: A Disease of Motor Neurons and Their Nonneuronal Neighbors
Séverine Boillée, Christine Vande Velde, Don W. Cleveland · 2006 · Neuron · 1.4K citations
Hallmarks of neurodegenerative diseases
David M. Wilson, Mark Cookson, Ludo Van Den Bosch et al. · 2023 · Cell · 1.4K citations
Reading Guide
Foundational Papers
Read Rosen et al. (1993) first for SOD1 discovery (6967 citations), then Wong et al. (1995) for mitochondrial mechanisms, followed by Boillée et al. (2006) for non-neuronal roles.
Recent Advances
Renton et al. (2013) reviews genetics state with SOD1 context; compare to C9orf72 expansion (Renton et al., 2011).
Core Methods
Transgenic SOD1 mice (G93A line); electron microscopy for vacuoles; Western blots for aggregates; antisense oligonucleotides for silencing.
How PapersFlow Helps You Research SOD1 Mutations in Familial ALS
Discover & Search
Research Agent uses searchPapers('SOD1 mutations ALS mitochondria') to retrieve Rosen et al. (1993), then citationGraph reveals downstream Wong et al. (1995) on vacuolar degeneration, and findSimilarPapers expands to Boillée et al. (2006). exaSearch uncovers patient-derived iPSC models linking SOD1 to ER stress.
Analyze & Verify
Analysis Agent applies readPaperContent on Wong et al. (1995) to extract mitochondrial pathology data, verifyResponse with CoVe cross-checks claims against Rosen et al. (1993), and runPythonAnalysis plots citation timelines or aggregates SOD1 mutation frequencies from supplementary tables. GRADE grading scores evidence strength for toxic gain-of-function claims.
Synthesize & Write
Synthesis Agent detects gaps in SOD1 refolding chaperone trials, flags contradictions between aggregation independence (Bruijn et al., 1998) and enzymatic models. Writing Agent uses latexEditText for manuscript sections, latexSyncCitations integrates Rosen et al. (1993), and latexCompile generates review PDFs; exportMermaid diagrams SOD1 toxicity pathways.
Use Cases
"Run statistical analysis on SOD1 mutation prevalence in familial ALS cohorts from 1993-2013 papers."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas aggregation of mutation frequencies from Rosen et al. 1993 and Renton et al. 2013) → matplotlib survival curves output.
"Write LaTeX review section on SOD1 mitochondrial toxicity with citations."
Synthesis Agent → gap detection → Writing Agent → latexEditText('SOD1 vacuolar degeneration') → latexSyncCitations (Wong et al. 1995, Boillée et al. 2006) → latexCompile → PDF with figure.
"Find GitHub repos analyzing SOD1 ALS mouse model data."
Research Agent → paperExtractUrls (Wong et al. 1995) → paperFindGithubRepo → githubRepoInspect → code for mitochondrial vacuole quantification shared with researcher.
Automated Workflows
Deep Research workflow scans 50+ SOD1 papers via searchPapers → citationGraph → structured report on mutation spectra (Rosen et al. 1993). DeepScan's 7-step chain verifies non-cell-autonomous claims (Boillée et al. 2006) with CoVe checkpoints and GRADE scoring. Theorizer generates hypotheses on SOD1-ER stress links from aggregated abstracts.
Frequently Asked Questions
What defines SOD1 mutations in familial ALS?
SOD1 mutations cause 20% familial ALS via toxic gain-of-function, first reported by Rosen et al. (1993) with 6967 citations identifying Cu/Zn SOD1 gene links.
What are key methods studying SOD1 ALS?
Transgenic mice expressing human mutant SOD1 (G93A, G37R) model disease; electron microscopy shows mitochondrial vacuoles (Wong et al., 1995). Aggregation assays confirm toxicity independence (Bruijn et al., 1998).
What are seminal papers on SOD1 ALS?
Rosen et al. (1993, Nature, 6967 citations) discovered SOD1 mutations; Wong et al. (1995, Neuron, 1429 citations) linked to mitochondrial damage; Boillée et al. (2006, Neuron, 1405 citations) showed glial involvement.
What open problems remain in SOD1 ALS research?
Selective mutant silencing without wild-type loss; ER stress contributions unclear; translating mouse model efficacy to humans (Renton et al., 2013).
Research Amyotrophic Lateral Sclerosis Research with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching SOD1 Mutations in Familial ALS with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers